263 related articles for article (PubMed ID: 25711212)
1. Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease.
Takahashi K; Kong Q; Lin Y; Stouffer N; Schulte DA; Lai L; Liu Q; Chang LC; Dominguez S; Xing X; Cuny GD; Hodgetts KJ; Glicksman MA; Lin CL
J Exp Med; 2015 Mar; 212(3):319-32. PubMed ID: 25711212
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.
Kong Q; Chang LC; Takahashi K; Liu Q; Schulte DA; Lai L; Ibabao B; Lin Y; Stouffer N; Das Mukhopadhyay C; Xing X; Seyb KI; Cuny GD; Glicksman MA; Lin CL
J Clin Invest; 2014 Mar; 124(3):1255-67. PubMed ID: 24569372
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of tripartite synapses as a potential therapeutic strategy for Alzheimer's disease: a preclinical study in rTg4510 mice.
Foster JB; Lashley R; Zhao F; Wang X; Kung N; Askwith CC; Lin L; Shultis MW; Hodgetts KJ; Lin CG
Alzheimers Res Ther; 2019 Aug; 11(1):75. PubMed ID: 31439023
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease.
Zumkehr J; Rodriguez-Ortiz CJ; Cheng D; Kieu Z; Wai T; Hawkins C; Kilian J; Lim SL; Medeiros R; Kitazawa M
Neurobiol Aging; 2015 Jul; 36(7):2260-2271. PubMed ID: 25964214
[TBL] [Abstract][Full Text] [Related]
5. Current approaches to enhance glutamate transporter function and expression.
Fontana AC
J Neurochem; 2015 Sep; 134(6):982-1007. PubMed ID: 26096891
[TBL] [Abstract][Full Text] [Related]
6. Partial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.
Meeker KD; Meabon JS; Cook DG
J Alzheimers Dis; 2015; 45(2):509-20. PubMed ID: 25589729
[TBL] [Abstract][Full Text] [Related]
7. Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures.
Sharma A; Kazim SF; Larson CS; Ramakrishnan A; Gray JD; McEwen BS; Rosenberg PA; Shen L; Pereira AC
Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21800-21811. PubMed ID: 31591195
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of astrocyte excitatory amino acid transporter 2 alleviates central sensitization in a rat model of chronic migraine.
Zhou X; Liang J; Wang J; Fei Z; Qin G; Zhang D; Zhou J; Chen L
J Neurochem; 2020 Nov; 155(4):370-389. PubMed ID: 31872442
[TBL] [Abstract][Full Text] [Related]
9. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease.
Tian G; Kong Q; Lai L; Ray-Chaudhury A; Lin CL
J Neurochem; 2010 May; 113(4):978-89. PubMed ID: 20193040
[TBL] [Abstract][Full Text] [Related]
11. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
[TBL] [Abstract][Full Text] [Related]
12. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
[TBL] [Abstract][Full Text] [Related]
13. Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer's disease.
Schallier A; Smolders I; Van Dam D; Loyens E; De Deyn PP; Michotte A; Michotte Y; Massie A
J Alzheimers Dis; 2011; 24(2):287-300. PubMed ID: 21297271
[TBL] [Abstract][Full Text] [Related]
14. Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.
Romera C; Hurtado O; Mallolas J; Pereira MP; Morales JR; Romera A; Serena J; Vivancos J; Nombela F; Lorenzo P; Lizasoain I; Moro MA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1327-38. PubMed ID: 17213861
[TBL] [Abstract][Full Text] [Related]
15. Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.
Limpert AS; Cosford ND
J Clin Invest; 2014 Mar; 124(3):964-7. PubMed ID: 24569369
[TBL] [Abstract][Full Text] [Related]
16. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
[TBL] [Abstract][Full Text] [Related]
17. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease.
Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC
Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823
[TBL] [Abstract][Full Text] [Related]
18. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease.
Noristani HN; Verkhratsky A; Rodríguez JJ
Aging Cell; 2012 Oct; 11(5):810-22. PubMed ID: 22702392
[TBL] [Abstract][Full Text] [Related]
19. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.
Mitew S; Kirkcaldie MT; Dickson TC; Vickers JC
Neurobiol Aging; 2013 Oct; 34(10):2341-51. PubMed ID: 23643146
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid plaques induce neuritic dystrophy of nitric oxide-producing neurons in a transgenic mouse model of Alzheimer's disease.
Quinn J; Davis F; Woodward WR; Eckenstein F
Exp Neurol; 2001 Apr; 168(2):203-12. PubMed ID: 11259108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
